These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 31562831)
21. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy. Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902 [TBL] [Abstract][Full Text] [Related]
22. Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases. Di Bello F; de Angelis M; Siech C; Jannello LMI; Peñaranda NR; Tian Z; Goyal JA; Ruvolo C; Califano G; La Rocca R; Saad F; Shariat SF; de Cobelli O; Briganti A; Chun FKH; Puliatti S; Longo N; Karakiewicz PI Clin Genitourin Cancer; 2024 Oct; 22(5):102139. PubMed ID: 39003986 [TBL] [Abstract][Full Text] [Related]
23. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418 [TBL] [Abstract][Full Text] [Related]
24. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826 [TBL] [Abstract][Full Text] [Related]
25. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161 [TBL] [Abstract][Full Text] [Related]
26. Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. Sorce G; Chierigo F; Flammia RS; Hoeh B; Hohenhorst L; Tian Z; Goyal JA; Graefen M; Terrone C; Gallucci M; Chun FKH; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI Urol Oncol; 2022 Aug; 40(8):380.e19-380.e27. PubMed ID: 35431135 [TBL] [Abstract][Full Text] [Related]
27. Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model. Al-Alao O; Mueller-Leonhard C; Kim SP; Amin A; Tucci C; Kott O; Mega A; Golijanin D; Gershman B Urol Oncol; 2020 Mar; 38(3):76.e19-76.e28. PubMed ID: 31590968 [TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091 [TBL] [Abstract][Full Text] [Related]
29. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857 [TBL] [Abstract][Full Text] [Related]
30. Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients. Horlemann B; Würnschimmel C; Hoeh B; Sorce G; Chierigo F; Flammia RS; Tian Z; Saad F; Briganti A; Shariat SF; Galucci M; Chun FKH; Graefen M; Karakiewicz PI Clin Genitourin Cancer; 2022 Feb; 20(1):93.e1-93.e9. PubMed ID: 34620567 [TBL] [Abstract][Full Text] [Related]
31. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404 [TBL] [Abstract][Full Text] [Related]
32. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Bekelman JE; Handorf EA; Guzzo T; Evan Pollack C; Christodouleas J; Resnick MJ; Swisher-McClure S; Vaughn D; Ten Have T; Polsky D; Mitra N Value Health; 2013 Jun; 16(4):610-8. PubMed ID: 23796296 [TBL] [Abstract][Full Text] [Related]
33. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. Faiena I; Salmasi A; Mendhiratta N; Lenis AT; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K World J Urol; 2018 Nov; 36(11):1825-1833. PubMed ID: 29752514 [TBL] [Abstract][Full Text] [Related]
34. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082 [TBL] [Abstract][Full Text] [Related]
35. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients. Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084 [TBL] [Abstract][Full Text] [Related]
36. The effect of enhanced recovery after surgery on oncologic outcome following radical cystectomy for urothelial bladder carcinoma. Ma R; Sheybaee Moghaddam F; Ghoreifi A; Ladi-Seyedian S; Cai J; Miranda G; Aron M; Schuckman A; Desai M; Gill I; Daneshmand S; Djaladat H Surg Oncol; 2024 Jun; 54():102061. PubMed ID: 38513372 [TBL] [Abstract][Full Text] [Related]
37. Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis. Breau RH; Karnes RJ; Farmer SA; Thapa P; Cagiannos I; Morash C; Frank I BJU Int; 2014 Jun; 113(6):900-6. PubMed ID: 24053569 [TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593 [TBL] [Abstract][Full Text] [Related]
39. Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study. Rosiello G; Pecoraro A; Palumbo C; Knipper S; Luzzago S; Deuker M; Tian Z; Gandaglia G; Fossati N; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI World J Urol; 2021 Mar; 39(3):813-822. PubMed ID: 32424515 [TBL] [Abstract][Full Text] [Related]